Rapport Therapeutics (RAPP) Retained Earnings (2023 - 2026)
Rapport Therapeutics (RAPP) reported Retained Earnings of -$505000.0 for Q1 2026, up 99.66% year-over-year from -$252932.1 in Q1 2025, and up 99.79% quarter-over-quarter from -$235.2 million in Q4 2025.
Rapport Therapeutics (RAPP) Retained Earnings (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Retained Earnings data on file, last reported at -$505000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$505000.0, up 99.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$505000.0 (up 99.66% YoY), and the FY2025 annual result was -$235.2 million, down 44962.84% from the prior year.
- Retained Earnings rose to -$505000.0 in Q1 2026 per RAPP's latest filing, from -$235.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $400000.0 in Q3 2024 and troughed at -$235.2 million in Q4 2025.
- A 4-year average of -$84.4 million and a median of -$522000.0 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings slumped 95277.05% in 2025, then jumped 99.66% in 2026.
- A 4-year view of Retained Earnings shows it stood at $4000.0 in 2023, then sank by 13150.0% to -$522000.0 in 2024, then tumbled by 44962.84% to -$235.2 million in 2025, then surged by 99.79% to -$505000.0 in 2026.
- Business Quant data shows RAPP's Retained Earnings at -$505000.0 in Q1 2026, -$235.2 million in Q4 2025, and -$201.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | -505,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -505,000.00 |
| Dec 31, 2025 | -235.23 Mn |
| Sep 30, 2025 | -201.50 Mn |
| Jun 30, 2025 | -174.54 Mn |
| Mar 31, 2025 | -147.81 Mn |
| Dec 31, 2024 | -522,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | -183,000.00 |
| Dec 31, 2023 | 4,000.00 |